Mar 03, 2021 4:04pm EST DiaMedica Therapeutics to Report Fourth Quarter 2020 Financials and Provide a Business Update March 11, 2021
Jan 11, 2021 8:00am EST DiaMedica Therapeutics to Present at the H.C. Wainwright BioConnect Conference
Dec 15, 2020 8:04am EST DiaMedica Therapeutics Announces Enrollment of Last Patient in Diabetic Kidney Disease Cohort of Phase 2 REDUX CKD Study
Dec 10, 2020 8:03am EST DiaMedica Therapeutics Announces Successful Type B Meeting with FDA for the Study of DM199 in Patients with Acute Ischemic Stroke
Nov 19, 2020 9:04am EST DiaMedica Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
Nov 11, 2020 8:30am EST DiaMedica Therapeutics to Participate in 11th Annual Craig-Hallum Alpha Select Conference
Nov 04, 2020 4:30pm EST DiaMedica Provides a Business Update and Third Quarter 2020 Financial Results
Oct 28, 2020 8:30am EDT DiaMedica Therapeutics to Report Third Quarter 2020 Financial Results and Provide a Business Update November 5, 2020